Movement Disorders Clinical Practice

Article	Citations
Management of Advanced Therapies in Parkinson's Disease Patients in Times of Humanitarian Crisis: The COVID‐19 Experience	88
TikTok Tics: A Pandemic Within a Pandemic	82
Tics and TikTok: Functional Tics Spread Through Social Media	62
Physical Activity Changes and Correlate Effects in Patients with Parkinson's Disease during COVID‐19 Lockdown	48
Clinical Correlates of Functional Motor Disorders: An Italian Multicenter Study	45
The Cholinergic Brain in Parkinson's Disease	44
Prevalence of Non‐Motor Symptoms and Non‐Motor Fluctuations in Parkinson's Disease Using the MDS‐NMS	39
Impact of the COVID‐19 Pandemic on Parkinson's Disease and Movement Disorders	36
Open‐Label Phase 1 Futility Studies of Salsalate and Young Plasma in Progressive Supranuclear Palsy	35
Myoclonus and Cerebellar Ataxia Following COVID‐19	35
Challenges in Clinicogenetic Correlations: One Gene – Many Phenotypes	34
Can Autonomic Testing and Imaging Contribute to the Early Diagnosis of Multiple System Atrophy? A Systematic Review and Recommendations by the Movement Disorder Society Multiple System Atro	31
White Matter Hyperintensities Related to Parkinson's Disease Executive Function	30
White Matter Hyperintensities Mediate Impact of Dysautonomia on Cognition in Parkinson's Disease	30
Age Cutoff for Early‐Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's Disease	30
De Novo Movement Disorders and COVID‐19: Exploring the Interface	27
Reversible Myoclonus‐Ataxia as a Postinfectious Manifestation of COVID‐19	27
Parkinson's Disease Symptoms Have a Distinct Impact on Caregivers' and Patients' Stress: A Study Assessing the Consequences of the COVID‐19 Lockdown	25
Neuroimaging Detectable Differences between Parkinson's Disease Motor Subtypes: A Systematic Review	25
The Prevalence and Determinants of Neuropsychiatric Symptoms in Late‐Stage Parkinsonism	24
Perceived Worsening of Tics in Adult Patients with Tourette Syndrome after the COVID‐19 Outbreak	24
Pragmatic Approach on Neuroimaging Techniques for the Differential Diagnosis of Parkinsonisms	23
The Prevalence of Idiopathic or Inherited Isolated Dystonia: A Systematic Review and Meta‐Analysis	23
Accuracy of Smartphone Video for Contactless Measurement of Hand Tremor Frequency	23
DUOGLOBE: One‐Year Outcomes in a Real‐World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease	22

Sex Differences in Huntington's Disease: Evaluating the Enroll‐HD Database	21
Correlates of Psychological Distress in Patients with Parkinson's Disease During the COVID‐19 Outbreak	21
Myoclonus: An Electrophysiological Diagnosis	20
Milestones in Tremor Research: 10 Years Later	19
Systematic Review of Prevalence Studies of Progressive Supranuclear Palsy and Corticobasal Syndrome	19
Eye Movement Disorders in Movement Disorders	19
Disease Onset in Huntington's Disease: When Is the Conversion?	18
Coronavirus Disease 2019 and Related Parkinsonism: The Clinical Evidence Thus Far	18
Movement Disorders in the World of COVID‐19	17
Corticobasal Syndrome in a Patient with Anti‐IgLON5 Antibodies	16
Outcome of Hospitalized Parkinson's Disease Patients with and without COVID‐19	16
Cataplexy in Patients Harboring the KCNMA1 p.N999S Mutation	16
Virtual Parkinson's Disease Support Groups in the COVID‐19 Era: Social Connection in the Time of Social Distancing	16
Characterization of Gastrointestinal Symptom Type and Severity in Parkinson's Disease: A Case–Control Study in an Australian Cohort	16
Exploring Interrater Disagreement on Essential Tremor Using a Standardized Tremor Elements Assessment	15
Gender Differences in the Prevalence of Parkinson's Disease	15
Factors Associated with Health‐Related Quality of Life in Late‐Stage Parkinson's Disease	15
Antimuscarinic Anticholinergic Medications in Parkinson Disease: To Prescribe or Deprescribe?	15
Current Guidelines for Classifying and Diagnosing Cervical Dystonia: Empirical Evidence and Recommendations	15
Defining Atypical Anxiety in Parkinson's Disease	15
Subcortical Myoclonus in Coronavirus Disease 2019: Comprehensive Evaluation of a Patient	15
Cardiac 18F‐Dopamine PET Distinguishes PD with Orthostatic Hypotension from Parkinsonian MSA	15
Progression in Parkinson's Disease: Variation in Motor and Non‐motor Symptoms Severity and Predictors of Decline in Cognition, Motor Function, Disability, and Health‐Related Quality of Life as Assesse	15
Anticholinergics May Carry Significant Cognitive and Gait Burden in Parkinson's Disease	15
Cardiopulmonary Function and Aerobic Exercise in Parkinson's: A Systematic Review of the Literature	15
Task Force Consensus on Nosology and Cut‐Off Values for Axial Postural Abnormalities in Parkinsonism	15
Does the Country Make a Difference in Impulse Control Disorders? A Systematic Review	15
Clinical Impact of Deep Brain Stimulation on the Autonomic System in Patients with Parkinson's Disease	14
Women with Fragile X–associated Tremor/Ataxia Syndrome	13
Post‐Hypoxic Myoclonus after COVID‐19 Infection Recovery	13
Parkinsonism Versus Concomitant Parkinson's Disease in Fragile X–Associated Tremor/Ataxia Syndrome	13
The Montreal Cognitive Assessment: Is It Suitable for Identifying Mild Cognitive Impairment in Parkinson's Disease?	13
GPi‐DBS for KMT2B‐Associated Dystonia: Systematic Review and Meta‐Analysis	13
Incidence and Progression of Rapid Eye Movement Behavior Disorder in Early Parkinson's Disease	13
Abnormal Saccadic Oscillations Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Encephalopathy and Ataxia	13
Movement Disorders and Renal Diseases	13
Challenges in Clinicogenetic Correlations: One Phenotype – Many Genes	12
Some New and Unexpected Tauopathies in Movement Disorders	12
GTPase Regulator Associated with Focal Adhesion Kinase 1 (GRAF1) Immunoglobulin‐Associated Ataxia and Neuropathy	12
Apathy and Anxiety in De Novo Parkinson's Disease Predict the Severity of Motor Complications	12
Evaluation of Individualized Multi‐Disciplinary Inpatient Treatment for Functional Movement Disorders	12
Efficacy of Occupational Therapy Interventions on Quality of Life in Patients with Parkinson's Disease: A Systematic Review and Meta‐Analysis	12
Effects of Nabilone on Sleep Outcomes in Patients with Parkinson's Disease: A Post‐hoc Analysis of NMS‐Nab Study	12
Access and Use of Device‐Aided Therapies for Parkinson’s Disease in Denmark	12
Has Deep Brain Stimulation Changed the Very Long‐Term Outcome of Parkinson's Disease? A Controlled Longitudinal Study	11
Soft Signs in Essential Tremor Plus: A Prospective Study	11
Utility of Imaging of Nigrosome‐1 on 3T MRI and Its Comparison with 18F‐DOPA PET in the Diagnosis of Idiopathic Parkinson Disease and Atypical Parkinsonism	11
Management of Parkinson's Disease During Pregnancy: Literature Review and Multidisciplinary Input	11
Myoclonus‐Ataxia Syndromes: A Diagnostic Approach	11
Multidimensional Apathy: The Utility of the Dimensional Apathy Scale in Huntington's Disease	11

Myoclonus and COVID‐19: A Challenge for the Present, a Lesson for the Future	11
Level I PD‐MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia	11
Current Knowledge on the Evolution of Care Partner Burden, Needs, and Coping in Parkinson's Disease	11
Acute Post‐Infectious Cerebellar Ataxia Due to COVID‐19	10
Mortality and Institutionalization After Percutaneous Endoscopic Gastrostomy in Parkinson's Disease and Related Conditions	10
Psychiatric Comorbidities in Functional Movement Disorders: A Retrospective Cohort Study	10
Characteristics and Outcomes of Parkinson's Disease Individuals Hospitalized with COVID‐19 in a New York City Hospital System	10
Does Depression Contribute to the Bladder and Bowel Complaint in Parkinson's Disease Patients?	10
Homer‐3 Antibody Disease: A Potentially Treatable MSA‐C Mimic	10
Striatal Dopamine Loss in Early Parkinson's Disease: Systematic Review and Novel Analysis of Dopamine Transporter Imaging	10
Depression and Apathy across Different Variants of Progressive Supranuclear Palsy	9
α‐Synuclein Seed Amplification Assays in the Diagnosis of Synucleinopathies Using Cerebrospinal Fluid—A Systematic Review and Meta‐Analysis	9
Task Specific Tremor Subsequently Developing into Parkinson's Disease: Case Series	9
Dream Content Predicts Motor and Cognitive Decline in Parkinson's Disease	9
Aggression Toward Others Misdiagnosed as Primary Tics	9
Real‐World Nonmotor Changes in Patients with Parkinson's Disease and Motor Fluctuations: J‐FIRST	9
Preoperative Levodopa Response and Deep Brain Stimulation Effects on Motor Outcomes in Parkinson's Disease: A Systematic Review	9
Parkinson's Disease Medication Prescribing and Administration During Unplanned Hospital Admissions	9
Driving with Tic Disorders: An International Survey of Lived Experiences	8
VPS13D: One Family, Same Mutations, Two Phenotypes	8
Heterozygous EIF2AK2 Variant Causes Adolescence‐Onset Generalized Dystonia Partially Responsive to DBS	8
Measuring Medication Adherence in Parkinson's Disease: A Systematic Review of Contributing Components in Rating Scales	8
Beyond Typical Ataxia Telangiectasia: How to Identify the Ataxia Telangiectasia‐Like Disorders	8
Persistence of Facio‐Skeletal Myorhythmia During Sleep in anti‐IgLON5 Disease	8
Is There a Difference in Autonomic Dysfunction Between Multiple System Atrophy Subtypes?	8
Neuropsychiatric Symptoms Are Associated with Dementia in Parkinson's Disease but Not Predictive of it	8
Ethnic Disparities in Treatment of Chronic Pain in Individuals with Parkinson's Disease Living in the United Kingdom	8
Clinical Profile and Treatment Outcomes of Hypermanganesemia with Dystonia 1 and 2 among 27 Indian Children	8
New AARS2 Mutations in Two Siblings With Tremor, Downbeat Nystagmus, and Primary Amenorrhea: A Benign Phenotype Without Leukoencephalopathy	8
Theta Burst Deep Brain Stimulation in Movement Disorders	8
A Convenient Prognostic Tool and Staging System for Progressive Supranuclear Palsy	8
The Power of Musification: Sensor‐Based Music Feedback Improves Arm Swing in Parkinson's Disease	8
Thyroid Disorders and Movement Disorders—A Systematic Review	7
Conventional Magnetic Resonance Imaging in the Diagnosis of Parkinsonian Disorders: A Meta‐Analysis	7
Channelopathies Are a Frequent Cause of Genetic Ataxias Associated with Cerebellar Atrophy	7
A Systematic Review of the Spectrum and Prevalence of Non‐Motor Symptoms in Adults with Hereditary Cerebellar Ataxias	7
Delineation of Apathy Subgroups in Parkinson's Disease: Differences in Clinical Presentation, Functional Ability, Health‐related Quality of Life, and Caregiver Burden	7
Late‐Onset Tay‐Sachs Disease in an Irish Family	7
The Efficacy and Safety of Pridopidine on Treatment of Patients with Huntington's Disease: A Systematic Review and Meta‐Analysis	7
Visuospatial Deficits Are Associated with Pisa Syndrome and not Camptocormia in Parkinson's Disease	7
Levodopa/Carbidopa Intestinal Gel Long‐Term Outcome in Parkinson's Disease: Focus on Dyskinesia	7
Movement Disorders and Liver Disease	7
Congenital Ichthyosis in a Case of Spinocerebellar Ataxia Type 34: A Novel Presentation for a Known Mutation	7
Possible EIF2AK2‐Associated Stress‐Related Neurological Decompensation with Combined Dystonia and Striatal Lesions	7
Clinical Features of Idiopathic Normal Pressure Hydrocephalus: Critical Review of Objective Findings	7
Movement Disorders Associated with Hypogonadism	7
Adult‐Onset KMT2B‐Related Dystonia Responsive to Deep Brain Stimulation	7
Higher Risk, Higher Reward? Self‐Reported Effects of Real‐World Cannabis Use in Parkinson's Disease	7
Another Twist in the Tale: Intrafamilial Phenotypic Heterogeneity in ANO3‐Related Dystonia	7
Laboratory‐Supported Multiple System Atrophy beyond Autonomic Function Testing and Imaging: A Systematic Review by the MoDiMSA Study Group	7
Reappearance of Symptoms after GPi‐DBS Discontinuation in Cervical Dystonia	7
Functionally Relevant Maculopathy and Optic Atrophy in Spinocerebellar Ataxia Type 1	7
Quantitative Assessment of Response to Long‐Term Treatment with Intravenous Immunoglobulin in Patients with Stiff Person Syndrome	7
Why People With Parkinson's Disease Experience Near‐Drowning—and How to Prevent It	7
Tics and Tic‐like Phenomena—Old Questions on a Grand New Scale Invited Editorial on TikTok and Tics	7
Lisdexamfetamine Therapy in Paroxysmal Non‐kinesigenic Dyskinesia Associated with the KCNMA1‐N999S Variant	7
Asleep Deep Brain Stimulation of the Nucleus Ventralis Intermedius for Essential Tremor Using Indirect Targeting and Interventional Magnetic Resonance Imaging: Single‐Institution Case Serie	7
Successful Treatment of Levodopa/Carbidopa Intestinal Gel Associated “Biphasic‐like” Dyskinesia with Pallidal Deep Brain Stimulation	7
The Role of Focused Ultrasound in the Management of Movement Disorders: Insights after 5 Years of Experience	7
POLR3A‐Related Disorder Presenting with Late‐Onset Dystonia and Spastic Paraplegia	7
Telehealth Transdiagnostic Cognitive Behavioral Therapy for Depression in Parkinson's Disease: A Pilot Randomized Controlled Trial	7
Parkinsonism and Positive Dopamine Transporter Imaging in a Patient with a Novel KMT2B Variant	7
Psychiatric Manifestations of ATP13A2 Mutations	6
Anti‐IgLON5 Disease with Isolated Hemichorea: A Case Report and Review of the Literature	6
Feasibility and Safety of Telerehabilitation for Physiotherapy Interventions in Movement Disorders Patients	6
Clozapine Is Severely Underused in Parkinson's Disease Patients	6
Clinical Features, Neuroimaging, and Levodopa‐Responsiveness in Holmes' Tremor: A Video‐Based Case‐Series with a Review of the Literature	6
A Case Report of Chronic Progressive Pancerebellar Syndrome with Leukoencephalopathy:L‐2 Hydroxyglutaric Aciduria	6
Unusual Head Movements in Anti‐IgLON5 Disease	6
Self‐Reported Barriers to Exercise and Factors Impacting Participation in Exercise in Patients with Parkinson's Disease	6
Efficacy of Istradefylline for the Treatment of ADCY5‐Related Disease	6
Urodynamic Evaluation in Multiple System Atrophy: A Retrospective Cohort Study	6
Dopamine Transporter Deficiency Syndrome: A Case with Hyper‐ and Hypokinetic Extremes	6
Opicapone Efficacy and Tolerability in Parkinson's Disease Patients Reporting Insufficient Benefit/Failure of Entacapone	6
Hemiplegic Migraine in Glut1 Deficiency Syndrome and Paroxysmal Dyskinesia at Ketogenic Diet Induction: Case Report and Literature Review	6
Associations Between Fluctuations in Daytime Sleepiness and Motor and Non‐Motor Symptoms in Parkinson's Disease	6
Severe Early‐Onset Parkinsonian Syndrome Caused by PLA2G6 Heterozygous Variants	6
Tremor and Movement Slowness Are Two Unrelated Adverse Effects Induced by Valproate Intake	6
Association Between Olfactory Impairment and Disease Severity and Duration in Parkinson's Disease	6
Co‐Occurrence of Apathy and Impulsivity in Progressive Supranuclear Palsy	6

Biallelic PTRHD1 Frameshift Variants Associated with Intellectual Disability, Spasticity, and Parkinsonism	6
Imaging Evidence of Nigrostriatal Degeneration in DYT‐PRKRA	6
Spastic Paraplegia Type 7 and Movement Disorders: Beyond the Spastic Paraplegia	6
Advanced‐Stage Parkinson's Disease: From Identification to Characterization Using a Nationwide Database	6
White Matter Hyperintensities in the Synucleinopathies: Orthostatic Hypotension, Supine Hypertension, or Both?	6
Quantitative REM Sleep without Atonia in Parkinson's Disease and Essential Tremor	6
Genetic Movement Disorders Commonly Seen in Asians	6
Characterization of Non‐Motor Fluctuations Using the Movement Disorder Society Non‐Motor Rating Scale	6
APP‐Related Corticobasal Syndrome: Expanding the List of Corticobasal Degeneration Look Alikes	6
Patients with Cervical Dystonia Demonstrated Decreased Cognitive Abilities and Visual Planning Compared to Controls	5
Generalized Chorea and JAK2V617F Mutation‐Positive Myeloproliferative Disorders	5
Assistive Devices for Personal Mobility in Parkinson's Disease: A Systematic Review of the Literature	5
CORE‐Myoclonus Syndrome: A Proposed Neurological Initial Manifestation of COVID‐19	5
SPG15: A Rare Correlation with Atypical Juvenile Parkinsonism Responsive to Levodopa	5
Clinical and Imaging Profile of Patients with Palatal Tremor	5
Does the Anti‐Tau Strategy in Progressive Supranuclear Palsy Need to Be Reconsidered? No	5
Determining the Validity of Conducting Rating Scales in Friedreich Ataxia through Video	5
A Cross‐Sectional Comprehensive Assessment of the Profile and Burden of Non‐motor Symptoms in Relation to Motor Phenotype in the Nigeria Parkinson Disease Registry Cohort	5
Complex Movement Disorders in a Boy with PURA Syndrome	5
Predicting Outcome in a Cohort of Isolated and Combined Dystonia within Probabilistic Brain Mapping	5
Levodopa Equivalent Dose of Safinamide: A Multicenter, Longitudinal, Case–Control Study	5
Measurement Properties of Clinical Scales Rating the Severity of Blepharospasm: A Multicenter Observational Study	5
Biallelic Loss‐of‐Function NDUFA12 Variants Cause a Wide Phenotypic Spectrum from Leigh/Leigh‐Like Syndrome to Isolated Optic Atrophy	5
Brittle Biballism‐Dystonia in a Pediatric Patient with GNAO1 Mutation Managed Using Pallidal Deep Brain Stimulation	5
Life‐Space Mobility and Parkinson's Disease. A Multiple‐Methods Study	5
Single‐Center Study of 103 Consecutive Parkinson's Disease Patients with Levodopa‐Carbidopa Intestinal Gel	5
Prodromal Markers of Upper Limb Deficits in FMR1 Premutation Carriers and Quantitative Outcome Measures for Future Clinical Trials in Fragile X‐associated Tremor/Ataxia Syndrome	5
Deep Brain Stimulation in Parkinson's Disease: Still Effective After More Than 8 Years	5
Symptom‐Triggered Attention to Self as a Possible Trigger of Functional Comorbidity	5
Toward e‐Scales: Digital Administration of the International Parkinson and Movement Disorder Society Rating Scales	5
Apraxia of Lid Opening in Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease—Frequency, Risk Factors and Response to Treatment	5
Sars‐Cov‐2 in a Patient with Acute Chorea: Innocent Bystander or Unexpected Actor?	5
Segmental Myorhythmia with Palatal Tremor Due to Bilateral Hypertrophic Olivary Degeneration in Wilson Disease	5
The Effect of Education on Symptom Onset and Severity of Huntington's Disease	5
Modifiable Comorbidities Associated with Cognitive Decline in Parkinson's Disease	5
Pilot Study to Evaluate Pimavanserin for the Treatment of Motor and Behavioral Symptoms of Tourette Syndrome	5
The Spectrum of Movement Disorders in Cases with Osmotic Demyelination Syndrome	5
Experience in Genetic Counseling for GBA1 Variants in Parkinson's Disease	5
Have We Forgotten What Tics Are? A Re‐Exploration of Tic Phenomenology in Youth with Primary Tics	5
Combining Device‐Aided Therapies in Parkinson's Disease: A Case Series and a Literature Review	5
A Novel Phenotype Associated with CaSR‐Related Familial Brain Calcifications	5
Beyond the Dopaminergic System: Lessons Learned from levodopa Resistant Symptoms in Parkinson's Disease	5
Parkinsonism in Patients with Neuronopathic (Type 3) Gaucher Disease: A Case Series	5
Abstracts	5
Safety of Bilateral Staged Magnetic Resonance‐Guided Focused Ultrasound Thalamotomy for Essential Tremor	5
A Placebo‐Controlled Study to Assess the Sensitivity of Finger Tapping to Medication Effects in Parkinson's Disease	5
Sudden Onset, Fixed Dystonia and Acute Peripheral Trauma as Diagnostic Clues for Functional Dystonia	5
Benign SLC39A14 Course of Dystonia‐Parkinsonism Secondary to Inherited Manganese Accumulation	5
Generalized Dystonia/Parkinsonism and Double‐Doughnut Sign in Dengue Encephalitis	5
Deep Brain Stimulation Impact on Social and Occupational Functioning in Parkinson's Disease with Early Motor Complications	5
Tourette Syndrome and Driving	5
Geste Antagoniste Effects on Motor Performance in Dystonia—A Kinematic Study	5
Bilateral Focused Ultrasound Pallidotomy for Parkinson‐Related Facial Dyskinesia—A Case Report	5
Multiculturalism: A Challenge for Cognitive Screeners in Parkinson's Disease	4
The Successful Three‐Year Outcome of Deep Brain Stimulation in Gaucher Disease Type 1 Associated Parkinson's Disease: A Case Report	4
Do Patients with Progressive Supranuclear Palsy Have Episodic Memory Impairment? A Systematic Review	4
Hereditary Spastic Paraplegia 7 Presenting as Multifocal Dystonia with Prominent Cranio‐Cervical Involvement	4
β‐Blocker–Induced Tremor	4
Benefits and Risks of a Staged‐Bilateral VIM Versus Unilateral VIM DBS for Essential Tremor	4
Dystonia and Myelopathy in a Case of Stress‐Induced Childhood‐Onset Neurodegeneration with Ataxia and Seizures (CONDSIAS)	4
Gender Differences in Functional Movement Disorder: Sociocultural or Biological?	4
Spinocerebellar Ataxia 40: Another Etiology Underlying Essential Tremor Syndrome	4
Telemedicine Aids in Initial Deep Brain Stimulation Programming for Dystonia	4
Subthalamic Nucleus Stimulation in Parkinson's Disease: 5‐Year Extension Study of a Randomized Trial	4
Late‐Onset Chorea in JAK2‐Associated Essential Thrombocythemia	4
Telemonitoring via Questionnaires Reduces Outpatient Healthcare Consumption in Parkinson's Disease	4
False Positive Hoover's Sign in Apraxia	4
ADCY5‐Induced Dyskinetic Storm Rescued with Pallidal Deep Brain Stimulation in a 46‐Year‐Old Man	4
Deep Brain Stimulation of the Nucleus Basalis of Meynert for Parkinson's Disease Dementia: A 36 Months Follow Up Study	4
Brain Bank Questionnaire Helps in Differential Diagnosis of Movement Disorders: An Autopsy Study of 150 Patients	4
STUB1‐Related Ataxias: A Challenging Diagnosis	4
DYT‐TUBB4A (DYT4 Dystonia): Clinical Anthology of 11 Cases and Systematized Review	4
Obstructive Sleep Apnea and Other Vascular Risk factors' Impact on Non‐Motor Symptoms in Parkinson's Disease	4
Morbidity Milestones Demonstrate Long Disability‐Free Survival in Parkinson's Disease Patients with Deep Brain Stimulation of the Subthalamic Nucleus	4
Surgical Management of Parkinson's Disease in the Elderly	4
Impulse Control Disorders in Parkinson's Disease: Has COVID‐19 Related Lockdown Been a Trigger?	4
The Head Retraction Reflex in Niemann‐Pick Type C: A Novel Diagnostic Clue	4
Video Anthology of Movement Disorders Due to Infections in South Asia	4
Longitudinal Follow‐Up of Mood in Cervical Dystonia and Influence on Age at Onset	4
Cardiac Involvement in Movement Disorders	4
Antiphospholipid‐Related Chorea: Two Case Reports and Role of Metabolic Imaging	4
Chorea in IgLON5‐Mediated Autoimmune Encephalitis	4
An Open‐Label Phase 2a Study to Evaluate the Safety and Tolerability of Perampanel in Cervical Dystonia	4
Intermittent Apomorphine Use for off Period Rescue in Parkinson's Disease: A Pragmatic Review of over Three Decades of Clinical Experience	4
Phenomenology of Muscle Spasms in Satoyoshi Syndrome and Treatment With Botulinum Toxin Injections	4
Intraventricular Baclofen Following Deep Brain Stimulation in a Child with Refractory Status Dystonicus	4
Factors Associated with Headache and Nausea During Magnetic Resonance–Guided Focused Ultrasound for Tremor	4
Oro‐Bucco‐Lingual Dyskinesia, Weight Loss, and Cognitive Decline in Anti‐DPPX Antibody‐Mediated Encephalitis	4
Reckless Generosity, Parkinson's Disease and Dopamine: A Case Series and Literature Review	4
Abstracts	4
Prevalence and Incidence of Nonmotor Symptoms in Individuals with and Without Parkinson's Disease	4
CRMP‐5‐IgG Associated Paraneoplastic Chorea	4
A Case of MPAN with “Eye of the Tiger Sign,” Mimicking PKAN	4
Prevalence and Risk Factors for Double Vision in Parkinson Disease	4
A Case of Autosomal Dominant Ataxia with Vocal Cord Palsy Attributed to a Mutation in the PRNP Gene	4